Kim Cook: Bringing Rare Blood Cancers Into the Conversation
Kim Cook, Senior Manager of Information Security Risk Management at Instructure, shared a post on LinkedIn:
“September is Blood Cancer Awareness Month, and for our family, that means shining a light on something we live with every day.
My husband has Essential Thrombocythemia (ET), a rare blood cancer that causes the bone marrow to produce too many platelets.
It’s part of a group called myeloproliferative neoplasms (MPNs), which many people have never heard of.
ET doesn’t always look like cancer from the outside.
It’s managed through lifelong monitoring, medication, and a lot of patience.
Awareness helps others understand that rare blood cancers exist and that early detection can make a real difference.
If you’ve never heard of ET or MPNs, take a moment to learn.
The more we talk about them, the less invisible they become.”
Stay updated with Hemostasis Today.
-
Sep 3, 2026, 00:44Same goal, Different molecular strategy – Which FVIIIa Mimetic Gets There How? – RPTH Journal
-
Sep 3, 2026, 00:33Hannah Isles: Interesting Link between Aging, Serotonin, Platelets and COVID-19 Severity
-
Sep 3, 2026, 00:22Danny Hsu: Paradigm Shift in PE Management? – Unpacking the PRAGUE-26 Trial
-
Sep 3, 2026, 00:14Leonardo Roever: Antiphospholipid Antibodies Present in 19% of Ischemic Stroke Cases
-
Sep 3, 2026, 00:03Jochebed Adwoa Sutherland: First Reported Case of Breast Mondor’s Disease in a Patient Living with Sickle Cell
-
Sep 2, 2026, 23:50Shashank Joshi: Individualized vs. Standard BP Control Shows Similar 90-Day Outcomes
-
Sep 2, 2026, 18:26Strengthening Comprehensive Care for Inherited Bleeding Disorders in Ecuador – World Federation of Hemophilia
-
Sep 2, 2026, 18:24Zeeshan Ahmed Khattak: Managing Febrile Neutropenia in Hematology/Oncology and Transplant Patients
-
Sep 2, 2026, 18:22Mark Heyland: The Role of Thromboinflammation in Fracture Non-Union